Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SRRK · against 226 other Healthcare companies of similar size
Ranked #98 of 227 · scores higher than 57% of peers · safety percentile 57
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)30 peers with a safety percentile of 50–59, including SRRK · Click a bar to see the companies
A mix: stronger current ratio, but weaker debt / equity than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | SRRK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 219 reported | 0.80× | 0.24× | 19% | 33% | |
| BetaLower is better · 226 reported | 0.68 | 0.54 | 38% | 33% | |
| Current ratioHigher is better · 218 reported | 7.02× | 2.78× | 81% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 3.6B USD | 99 | ||
| 4 | 3.1B EUR (≈$3.4B) | 99 | 100 | |
| 5 | 9.0B USD | 98 | 51 | |
| 94 | 3.4B USD | 58 | 55 | |
| 95 | 5.0B USD | 58 | 60 | |
| 96 | 1.03T JPY (≈$7.0B) | 57 | 64 | |
| 97 | 20.7B CNY (≈$2.9B) | 57 | 51 | |
| 98 | 5.4B USD | 57 | 24 | |
| 99 | 23.8B CNY (≈$3.3B) | 56 | 54 | |
| 100 | 8.4B USD | 56 | 67 | |
| 101 | 43.1B CNY (≈$6.0B) | 55 | 72 | |
| 102 | 9.4B USD | 55 | 70 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score